Advertisement
Screener

CervoMed Inc. (CRVO) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

CervoMed Inc. Financing Cash Flow

CervoMed Inc. (CRVO) reported Financing Cash Flow of $18.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07

  • CervoMed Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $18.91M, a 312.17% increase year-over-year.
  • CervoMed Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $13.80K.
  • CervoMed Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00.
  • CervoMed Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
  • CervoMed Inc. net cash provided by (used in) financing activities for fiscal 2025 was $4.59M, a 90.11% decline from fiscal 2024.
  • CervoMed Inc. net cash provided by (used in) financing activities for fiscal 2024 was $46.40M, a 316.16% increase from fiscal 2023.
  • CervoMed Inc. net cash provided by (used in) financing activities for fiscal 2023 was $11.15M.
  • CervoMed Inc. net cash provided by (used in) financing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2026-06-30$18.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$18.93M
10-Q · filed 2026-08-07
$18.93M
derived: sum of 3 quarters · filed 2026-08-07
$18.93M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$13.80K
10-Q · filed 2026-05-15
$13.80K
derived: sum of 2 quarters · filed 2026-05-15
$13.80K
derived: sum of 3 quarters · filed 2026-05-15
$4.60M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$0.00
derived: sum of 2 quarters · filed 2026-03-13
$4.59M
derived: sum of 3 quarters · filed 2026-08-07
$4.59M
10-K · filed 2026-03-13
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$4.59M
derived: sum of 2 quarters · filed 2026-08-07
$4.59M
10-Q · filed 2025-11-07
$4.59M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$4.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$4.59M
10-Q · filed 2026-08-07
$4.59M
derived: sum of 3 quarters · filed 2026-08-07
$4.58M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$0.00
10-Q · filed 2026-05-15
$0.00
derived: sum of 2 quarters · filed 2026-05-15
-$13.34K
derived: sum of 3 quarters · filed 2026-05-15
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
-$13.34K
derived: sum of 2 quarters · filed 2026-03-13
$46.40M
10-K · filed 2026-03-13
2024-09-30-$13.34K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$46.40M
10-Q · filed 2025-11-07
2024-06-30$46.41M
10-Q · filed 2025-08-08
2023-12-31-$93.38K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
$11.15M
derived: sum of 2 quarters · filed 2025-03-17
$11.15M
derived: sum of 3 quarters · filed 2025-03-17
$11.15M
10-K · filed 2025-03-17
2023-09-30$11.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$11.24M
derived: sum of 2 quarters · filed 2024-11-12
$11.24M
10-Q · filed 2024-11-12
$11.24M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$0.00
10-Q · filed 2024-08-09
$0.00
derived: sum of 3 quarters · filed 2024-08-09
-$5.00K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$0.00
10-Q · filed 2023-05-15
$0.00
derived: sum of 2 quarters · filed 2024-03-29
-$5.00K
derived: sum of 3 quarters · filed 2024-03-29
-$5.00K
derived: sum of 4 quarters · filed 2024-03-29
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
-$5.00K
derived: sum of 2 quarters · filed 2024-03-29
-$5.00K
derived: sum of 3 quarters · filed 2024-03-29
$0.00
10-K · filed 2024-03-29
$5.00K
10-K · filed 2023-03-24
2022-09-30-$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$5.00K
derived: sum of 2 quarters · filed 2023-11-13
$0.00
10-Q · filed 2023-11-13
$5.00K
10-Q · filed 2022-11-14
$0.00
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$5.00K
10-Q · filed 2023-08-08
$5.00K
derived: sum of 3 quarters · filed 2023-08-08
$5.00K
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$5.00K
10-Q · filed 2023-05-15
$5.00K
derived: sum of 2 quarters · filed 2023-05-15
$5.00K
derived: sum of 3 quarters · filed 2023-05-15
$5.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24
$0.00
derived: sum of 2 quarters · filed 2023-03-24
$0.00
derived: sum of 3 quarters · filed 2023-03-24
$33.30M
10-K · filed 2023-03-24
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$0.00
derived: sum of 2 quarters · filed 2022-11-14
$33.30M
10-Q · filed 2022-11-14
$33.30M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$33.30M
10-Q · filed 2022-08-12
$33.30M
derived: sum of 3 quarters · filed 2022-08-12
$33.15M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$33.30M
10-Q · filed 2022-05-12
$33.30M
derived: sum of 2 quarters · filed 2022-05-12
$33.15M
derived: sum of 3 quarters · filed 2022-05-12
$51.03M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18
-$141.40K
derived: sum of 2 quarters · filed 2022-03-18
$17.74M
derived: sum of 3 quarters · filed 2022-03-18
$17.89M
10-K · filed 2022-03-18
2020-09-30-$141.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$17.74M
derived: sum of 2 quarters · filed 2021-11-10
$17.89M
10-Q · filed 2021-11-10
$28.37M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$17.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$18.03M
10-Q · filed 2021-08-11
$28.51M
derived: sum of 3 quarters · filed 2021-08-11
$28.43M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$155.19K
10-Q · filed 2021-05-07
$10.63M
derived: sum of 2 quarters · filed 2021-05-07
$10.55M
derived: sum of 3 quarters · filed 2021-05-07
2019-12-31$10.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$10.40M
derived: sum of 2 quarters · filed 2021-03-17
$16.04M
10-K · filed 2021-03-17
2019-09-30-$80.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$5.57M
10-Q · filed 2020-11-12
2019-06-30$5.65M
10-Q · filed 2020-08-07
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
$0.00
derived: sum of 2 quarters · filed 2020-03-17
-$724.78K
derived: sum of 3 quarters · filed 2020-03-17
$9.87M
10-K · filed 2020-03-17
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$724.78K
derived: sum of 2 quarters · filed 2019-11-08
$9.87M
10-Q · filed 2019-11-08
$9.84M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$724.78K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$9.87M
10-Q · filed 2019-08-08
$9.84M
derived: sum of 3 quarters · filed 2019-08-08
$7.90M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$10.59M
10-Q · filed 2019-05-09
$10.56M
derived: sum of 2 quarters · filed 2019-05-09
$8.63M
derived: sum of 3 quarters · filed 2019-05-09
$16.63M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19
-$1.96M
derived: sum of 2 quarters · filed 2019-03-19
$6.04M
derived: sum of 3 quarters · filed 2019-03-19
$20.12M
10-K · filed 2019-03-19
2017-09-30-$1.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$6.07M
derived: sum of 2 quarters · filed 2018-11-13
$20.15M
10-Q · filed 2018-11-13
$20.10M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$8.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
$22.09M
10-Q · filed 2018-08-10
$22.03M
derived: sum of 3 quarters · filed 2018-08-10
2017-03-31$14.08M
10-Q · filed 2018-05-10
$14.03M
derived: sum of 2 quarters · filed 2018-05-10
2016-12-31-$54.35K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$1.83M
10-K · filed 2018-04-02
2016-09-30$1.88M
10-Q · filed 2017-11-13
2016-03-31$0.00
10-Q · filed 2017-05-15
2015-12-31$2.39M
10-K · filed 2017-03-31
2014-12-31$76.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$1.30M
derived: sum of 2 quarters · filed 2016-03-25
$30.31M
derived: sum of 3 quarters · filed 2016-03-25
$30.71M
10-K · filed 2016-03-25
2014-09-30-$1.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$30.23M
derived: sum of 2 quarters · filed 2015-11-12
$30.63M
10-Q · filed 2015-11-12
$30.63M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$31.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$32.01M
10-Q · filed 2015-08-12
$32.01M
derived: sum of 3 quarters · filed 2015-08-12
$32.52M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$400.00K
10-Q · filed 2015-05-11
$400.00K
derived: sum of 2 quarters · filed 2015-05-11
$910.00K
derived: sum of 3 quarters · filed 2015-05-11
$1.33M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$1.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03
$510.00K
derived: sum of 2 quarters · filed 2015-04-03
$927.50K
derived: sum of 3 quarters · filed 2015-04-03
$1.13M
10-K · filed 2015-04-03
2013-09-30$510.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$927.50K
derived: sum of 2 quarters · filed 2014-11-12
$1.13M
10-Q · filed 2014-11-12
$2.78M
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$417.50K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-14
$617.50K
10-Q · filed 2014-08-14
$2.27M
derived: sum of 3 quarters · filed 2014-08-14
$2.94M
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31$200.00K
10-Q/A · filed 2013-05-20
$1.85M
derived: sum of 2 quarters · filed 2014-04-23
$2.53M
derived: sum of 3 quarters · filed 2014-04-23
$2.96M
derived: sum of 4 quarters · filed 2014-04-23
2012-12-31$1.65M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23
$2.33M
derived: sum of 2 quarters · filed 2014-04-23
$2.76M
derived: sum of 3 quarters · filed 2014-04-23
$4.52M
10-K/A · filed 2014-04-23
2012-09-30$673.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19
$1.11M
derived: sum of 2 quarters · filed 2013-11-19
$2.87M
10-Q · filed 2013-11-19
$4.06M
derived: sum of 4 quarters · filed 2013-11-19
2012-06-30$437.03K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14
$2.20M
10-Q · filed 2013-08-14
$3.38M
derived: sum of 3 quarters · filed 2013-08-14
$4.17M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$1.76M
10-Q/A · filed 2013-05-20
$2.95M
derived: sum of 2 quarters · filed 2013-05-20
$3.73M
derived: sum of 3 quarters · filed 2013-05-20
2011-12-31$1.19M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24
$1.97M
derived: sum of 2 quarters · filed 2013-04-24
$13.11M
10-K/A · filed 2013-04-24
2011-09-30$783.96K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
$11.92M
10-Q · filed 2012-11-19
2011-06-30$11.14M
10-Q/A · filed 2012-09-07
2010-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21
$1.88M
derived: sum of 2 quarters · filed 2012-05-21
$3.37M
10-K · filed 2012-05-21
2010-09-30$836.58K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21
$2.32M
10-Q · filed 2011-11-21
2010-06-30$1.48M
10-Q · filed 2011-08-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celularity Inc (CELU)United States$0.038B-0.34
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30